An unusual feature of the c-mos oncogene is the lack of expression in mouse tissues. Recombinant plasmids that contain the strong adenovirus late promoter and different amounts of cellular DNA 5' to c-mos(rat) were constructed and tested in transfection and transcription assays. The cellular sequences inhibit RNA accumulation in mouse but not human cells and do not inhibit in vitro transcription of the plasmid DNAs.A feature unique to the c-mos oncogene (3) is the absence of expression in tissues from adult mice or mouse embryos (8,11,16). Since methylation of v-mos, the transforming gene of Moloney murine sarcoma virus (M-MSV), reduced the transforming capacity of the gene (12), the failure to express c-mos was originally attributed to the hypermethylated state of the c-mos gene in tissues (8). Recently, evidence was published for the presence of cellular DNA sequences upstream of c-mos(mouse) which inhibited its transforming capacity (26). As the assays used by Wood et al. to detect these inhibitory mouse sequences were based on the absence of focus formation after transfection (26), it was not clear whether the inhibition was at the level of RNA transcription, RNA processing, or translation, and we decided to examine directly the effect of these DNA sequences on RNA synthesis.We previously showed a high degree of homology between the c-mos genes of mice and rats and between their 5' flanking sequences (22). Because of these similarities, we chose to investigate the effect of the putative inhibitory sequences on the expression of c-mos(rat) and constructed the vectors shown in Fig. 1. They all contain c-mos(rat). Further, they contain the adenovirus 2 major late promoter (AdMLP) on a 455-base-pair (bp) XhoI-HindIII fragment which also contains the first leader exon and the adenovirus IVa2 promoter (19). However, we were unable to detect any activity of the adenovirus IVa2 promoter in the experiments described below, in agreement with earlier observations by Fire et al. (4). All vectors also contain different amounts of rat DNA that normally precedes c-mos(rat), placed between the AdMLP and the c-mos gene. Thus clones pAL,CMR-1, -2, and -3 contain, respectively, 850, 2,100 and 3,250 bp of rat DNA flanking the c-mos(rat) gene. The sequences around the HpaI site, harboring the putative inhibitory sequences, are present in clones pAL,CMR-2 and -3 but absent from pAL1CMR-1 and were shown previously to contain extensive homology to the similar region in mouse DNA (22). In vitro transcription (2, 5) was used to test the ability of the RNA polymerase II to start at the AdMLP and transcribe efficiently through the putative inhibitory sequences to the c-mos gene. Clones pAL1CMR-1 and -2 were digested with * Corresponding author.SmaI and HpaI, whereas pAL1CMR-3 was digested with SmaI and HindIII (Fig. 1). Thus, any transcription starting at the retroviral promoter in the long terminal repeat (LTR), which might interfere with initiation of transcription at the AdMLP, would generate a 30-nucleotide run-off transcript for e...